A tighter archive for life-science signals.
Search once, then narrow by source or topic.
Did Strong 2025 Revenue Growth and 10x Genomics Deal Just Shift CareDx's (CDNA) Investment Narrative? - Yahoo Finance
Did Strong 2025 Revenue Growth and 10x Genomics Deal Just Shift CareDx's (CDNA) Investment Narrative? - Yahoo Finance
Ex-CEO Behind Bars, 10x’s Clinical Ambitions, Pharma’s AI Gambit - Genetic Engineering and Biotechnology News
Ex-CEO Behind Bars, 10x’s Clinical Ambitions, Pharma’s AI Gambit - Genetic Engineering and Biotechnology News
Improving atlas-scale single-cell annotation models with hierarchical cross-entropy loss - Nature
Improving atlas-scale single-cell annotation models with hierarchical cross-entropy loss - Nature
4 Best Genetic Sequencing Stocks To Buy in 2026 - The Motley Fool
4 Best Genetic Sequencing Stocks To Buy in 2026 - The Motley Fool
Breaking Down 10x Genomics: 13 Analysts Share Their Views - Benzinga
Breaking Down 10x Genomics: 13 Analysts Share Their Views - Benzinga
Capsule Techs Expand Possibilities for Experiments on Single Cells - GenomeWeb
Capsule Techs Expand Possibilities for Experiments on Single Cells - GenomeWeb
Leerink Partners lowers 10X Genomics stock price target on pricing concerns - Investing.com
Leerink Partners lowers 10X Genomics stock price target on pricing concerns - Investing.com
Leerink Partners lowers 10X Genomics stock price target on pricing concerns - Investing.com
Leerink Partners lowers 10X Genomics stock price target on pricing concerns - Investing.com
Single-Cell Genome Sequencing Market Is Going to Boom |• 10x Genomics • Illumina - openPR.com
Single-Cell Genome Sequencing Market Is Going to Boom |• 10x Genomics • Illumina - openPR.com
A Look At 10x Genomics (TXG) Valuation After New Collaborations And Revenue Above Guidance - simplywall.st
A Look At 10x Genomics (TXG) Valuation After New Collaborations And Revenue Above Guidance - simplywall.st
A Look At 10x Genomics (TXG) Valuation After New Collaborations And Revenue Above Guidance - simplywall.st
A Look At 10x Genomics (TXG) Valuation After New Collaborations And Revenue Above Guidance - simplywall.st
10x Genomics, Inc. (NASDAQ:TXG) Stock Rockets 34% As Investors Are Less Pessimistic Than Expected - simplywall.st
10x Genomics, Inc. (NASDAQ:TXG) Stock Rockets 34% As Investors Are Less Pessimistic Than Expected - simplywall.st
10x Genomics, Inc. (NASDAQ:TXG) Stock Rockets 34% As Investors Are Less Pessimistic Than Expected - simplywall.st
10x Genomics, Inc. (NASDAQ:TXG) Stock Rockets 34% As Investors Are Less Pessimistic Than Expected - simplywall.st
Assessing 10x Genomics (TXG) Valuation After Recent Share Price Momentum - Yahoo Finance
Assessing 10x Genomics (TXG) Valuation After Recent Share Price Momentum - Yahoo Finance
J. Craig Venter launches genomics startup designed to boost diagnostic insights - Fierce Biotech
J. Craig Venter launches genomics startup designed to boost diagnostic insights - Fierce Biotech
10x Genomics to Report Fourth Quarter and Full Year 2025 Financial Results on February 12, 2026 - BioSpace
10x Genomics to Report Fourth Quarter and Full Year 2025 Financial Results on February 12, 2026 - BioSpace
10x Genomics Expands Clinical Ambitions As Momentum Outruns Analyst Targets - simplywall.st
10x Genomics Expands Clinical Ambitions As Momentum Outruns Analyst Targets - simplywall.st
10x Genomics to Report Fourth Quarter and Full Year 2025 Financial Results on February 12, 2026 - Nasdaq
10x Genomics to Report Fourth Quarter and Full Year 2025 Financial Results on February 12, 2026 - Nasdaq
Brand directory, kept in view
A rolling strip of the companies, platforms, CROs and device makers that show up across the coverage.
Open about page